| 000 | 01431 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518045423.0 | ||
| 264 | 0 | _c20190808 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1432-1335 | ||
| 024 | 7 |
_a10.1007/s00432-019-02958-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOronsky, Bryan | |
| 245 | 0 | 0 |
_aRRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition. _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _cAug 2019 |
||
| 300 |
_a2045-2050 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAzetidines _xpharmacology |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCytoprotection _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xgenetics |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aNitro Compounds _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 700 | 1 | _aScribner, Curtis | |
| 700 | 1 | _aAggarwal, Rahul | |
| 700 | 1 | _aCabrales, Pedro | |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 145 _gno. 8 _gp. 2045-2050 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-019-02958-4 _zAvailable from publisher's website |
| 999 |
_c29846704 _d29846704 |
||